medaus Pharmacy logo

The FDA announced the voluntary recall of several Medaus Pharmacy products on September 4, 2013, because the compounding pharmacy, based in Birmingham, Alabama, was unable to confirm the adequacy of quality control practices used by the independent laboratory that performs sterility testing for the affected products.

Non-sterile injectable products can expose patients to serious, life-threatening infections. Medaus Pharmacy’s recall is one of numerous recent safety alerts regarding sterility testing of compounded drugs by independent laboratories. (See: JCB Laboratories Recall and  Wellness Pharmacy Recall)

The following Medaus Pharmacy drugs have been recalled:

  • Testosterone CYP 200 mg/mL
    • Lot #: 130508-1
      • Expiration: 11/16/2013
  • Lipo injection with lidocaine
    • Lot #: 130510-26
      • Expiration: 11/16/2013
    • Lot #: 130610-24
      • Expiration: 12/07/2013
    • Lot #: 130709-68
      • Expiration: 01/05/2014
  • Taurine 50 mg/mL PF
    • Lot #: 130618-64
      • Expiration: 12/15/2013
  • L-Glutathione 200 mg/mL
    • Lot #: 130617-10
      • Expiration: 12/14/2013
  • Pyridoxine HCl 100 mg/mL NS PF
    • Lot #: 130531-31
      • Expiration: 11/27/13
  • Magnesium CHI 200 mg/mL
    • Lot #: 130307-60
      • Expiration: 09/03/2013
  • Sodium ascorbate 500 mg/mL PF
    • Lot #: 130702-1
      • Expiration: 12/29/2013
  • Sodium ascorbate 500 mg/mL non-corn PF
    • Lot #: 130613-8
      • Expiration: 12/10/2013

If you or a loved one has been affected by a compounding pharmacy product, contact us at www.andrewsthornton.com or toll free at 1-800-644-1734.

 

 

Share this Post
Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on TumblrShare on Google+Print this page